iShares Biotechnology ETF (NASDAQ:IBB) Shares Sold by Pursue Wealth Partners LLC

Pursue Wealth Partners LLC decreased its stake in iShares Biotechnology ETF (NASDAQ:IBB) by 27.4% in the 4th quarter, Holdings Channel reports. The firm owned 18,332 shares of the financial services provider’s stock after selling 6,907 shares during the quarter. iShares Biotechnology ETF accounts for approximately 1.6% of Pursue Wealth Partners LLC’s portfolio, making the stock its 19th biggest position. Pursue Wealth Partners LLC’s holdings in iShares Biotechnology ETF were worth $2,490,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors have also recently made changes to their positions in IBB. Glass Jacobson Investment Advisors llc lifted its holdings in shares of iShares Biotechnology ETF by 150.6% in the third quarter. Glass Jacobson Investment Advisors llc now owns 203 shares of the financial services provider’s stock valued at $25,000 after purchasing an additional 122 shares in the last quarter. Values First Advisors Inc. purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $43,000. Horizon Bancorp Inc. IN purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $44,000. Tennessee Valley Asset Management Partners purchased a new stake in shares of iShares Biotechnology ETF in the fourth quarter valued at about $44,000. Finally, Column Capital Advisors LLC purchased a new stake in shares of iShares Biotechnology ETF in the third quarter valued at about $49,000. Institutional investors and hedge funds own 62.45% of the company’s stock.

iShares Biotechnology ETF Stock Up 0.7 %

Shares of NASDAQ IBB traded up $0.82 on Friday, hitting $126.49. The company’s stock had a trading volume of 833,050 shares, compared to its average volume of 1,534,186. iShares Biotechnology ETF has a 12-month low of $111.83 and a 12-month high of $141.16. The stock has a 50 day moving average of $134.27 and a 200-day moving average of $129.74.

iShares Biotechnology ETF Dividend Announcement

The firm also recently declared a quarterly dividend, which was paid on Wednesday, March 27th. Shareholders of record on Friday, March 22nd were issued a $0.126 dividend. This represents a $0.50 annualized dividend and a dividend yield of 0.40%. The ex-dividend date was Thursday, March 21st.

iShares Biotechnology ETF Company Profile

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.